Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-02-24

Clinical Trial Update: Estimate the Efficiency of the Association of an Injection of Ketamine and the Venlafaxine in the Severe Major Depressive Disorder for Six Weeks [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the combination of ketamine injection and venlafaxine for six weeks in adults with major depressive disorder; the study status is compl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ketamine (ketamine)
  • Venlafaxine (Venlafaxine)

Snippet

Sponsor: University Hospital, Grenoble | Conditions: Major Depressive Disorder | Phase 3 | Status: COMPLETED